Company Zhuhai Rundu Pharmaceutical Co., Ltd.

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 24/09/2026			5-day change	1st Jan Change
10.85 ^CNY	-1.90%		+0.74%	-10.70%

08-20	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT

Business description: Zhuhai Rundu Pharmaceutical Co., Ltd.

Zhuhai Rundu Pharmaceutical Co Ltd is a China-based company primarily engaged in the production of APIs, intermediates, and chemical pharmaceuticals. The Company specializes in the production of specialty products in therapeutic areas such as cardiovascular and cerebrovascular systems, anti-infectives, digestive systems, antipyretics, analgesics, and anesthetics.

Number of employees: 1,655

Sales by Activity: Zhuhai Rundu Pharmaceutical Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Chemical Pharmaceutical Manufacturing	767M	861M	785M	683M	649M
Manufacturing of Active Pharmaceutical Ingredients	421M	502M	497M	494M	509M
Unallocated Other Operations	1.98M	9.01M	10.06M	5.53M	18.08M

See all business segments

Geographical breakdown of sales: Zhuhai Rundu Pharmaceutical Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
East China	303M	357M	343M	363M	326M
South China	312M	315M	260M	232M	236M
Central China	150M	191M	193M	186M	179M
Export	96.11M	156M	153M	139M	174M
Southwest China	138M	138M	156M	144M	131M
North China	115M	124M	91.3M	61.16M	72.29M
Northwest China	47.81M	57.07M	61.06M	41.96M	44.08M
Northeast	25.55M	25.29M	24M	15.02M	14.54M
Unallocated Other Business	1.98M	9.01M	10.06M	-	-

See all geographic segments

Executive Committee: Zhuhai Rundu Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Jie Liu CEO	Chief Executive Officer	50	21/10/2018
Shen Hua Shi DFI	Director of Finance/CFO	63	16/04/2011
Chun Yan You PRN	Corporate Officer/Principal	50	18/01/2018
Hong Juan Yan IRC	Investor Relations Contact	-	-
Jun Su SEC	Corporate Secretary	45	17/11/2022

See ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. governance

Composition of the Board of Directors: Zhuhai Rundu Pharmaceutical Co., Ltd.

Director	Title	Age	Since
Xin Min Chen CHM	Chairman	60	21/10/2018
Zhi Jun Hua CHM	Chairman	57	16/04/2011
Jie Liu BRD	Director/Board Member	50	30/03/2020
Chun Yan You BRD	Director/Board Member	50	30/03/2020
Ran Liao BRD	Director/Board Member	31	14/03/2023
Bo Wang BRD	Director/Board Member	64	14/03/2023
Jian Mu Ye BRD	Director/Board Member	59	14/03/2023
Wen Tan BRD	Director/Board Member	70	23/05/2019
Na Li BRD	Director/Board Member	40	07/11/2018
Jia Wei Guo BRD	Director/Board Member	34	14/05/2018

Composition of the Board of Directors

Shareholders: Zhuhai Rundu Pharmaceutical Co., Ltd.

Name	Stocks	%	Valuation
Huatai-PineBridge Fund Management Co., Ltd. 0.1586 %	408,200	0.1586 %	673 061 ¥
China Merchants Fund Management Co., Ltd. 0.1441 %	371,000	0.1441 %	611 723 ¥
Gfund Management Co., Ltd. 0.0985 %	253,700	0.0985 %	418 313 ¥
China Southern Asset Management Co., Ltd. 0.0386 %	99,300	0.0386 %	163 731 ¥
China Asset Management Co., Ltd. 0.0162 %	41,600	0.0162 %	68 592 ¥

List of ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. shareholders

Company details: Zhuhai Rundu Pharmaceutical Co., Ltd.

Zhuhai Rundu Pharmaceutical Co., Ltd.

6 Airport North Road

519040, Zhuhai

http://www.rdpharma.cn

address Zhuhai Rundu Pharmaceutical Co., Ltd.(002923)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.	-1.90%	+0.74%	-15.76%	-16.41%	552M
ELI LILLY AND COMPANY	+2.68%	+2.56%	+59.32%	+114.00%	1,026B
JOHNSON & JOHNSON	+0.56%	+0.17%	+53.19%	+68.90%	649B
ABBVIE INC.	+0.02%	+0.42%	+20.51%	+71.43%	468B
ROCHE HOLDING AG	+0.06%	+0.25%	+37.03%	+45.71%	352B
NOVARTIS AG	+1.16%	+4.10%	+21.99%	+29.39%	271B
ASTRAZENECA PLC	-0.24%	+2.18%	+10.14%	+12.26%	256B
AMGEN INC.	-0.01%	+6.91%	+45.42%	+52.15%	220B
GILEAD SCIENCES, INC.	-1.11%	-0.80%	+31.69%	+100.04%	188B
NOVO NORDISK A/S	+0.30%	-7.19%	-32.43%	-60.56%	170B
Average	+0.28%	+1.07%	+23.11%	+41.69%	359.97B
Weighted average by Cap.	+1.17%	+1.25%	+38.05%	+67.29%